Myoclonic Epilepsy
Symptoms, Doctors, Treatments, Advances & More

Myoclonic Epilepsy Overview

Save information for later
Sign Up

Learn About Myoclonic Epilepsy

What is the definition of Myoclonic Epilepsy?
Myoclonic epilepsy is a type of seizure disorder characterized by quick jerking movements due to uncontrolled muscle contractions caused by abnormal electrical impulses in the brain. Unlike grand mal (tonic-clonic) seizures, during a myoclonic seizure the affected individual does not lose consciousness. There are several types of myoclonic epilepsy, including infantile spasms, Lennox-Gastaut Syndrome, juvenile myoclonic epilepsy, and progressive myoclonic epilepsy, among others.
What are the symptoms of Myoclonic Epilepsy?
Symptoms of myoclonic epilepsy depend on the type and usually affects the neck, shoulders, and upper arms. Symptoms of myoclonic epilepsy may include quick, uncontrolled muscle jerks; rhythmic movements; arms flinging outward; knees pulling up; body stiffening; and unusual clumsiness. Myoclonic seizures may occur with atonic seizures, which cause limp muscles. When myoclonic epilepsy worsens, it is known as progressive myoclonic epilepsy, which is a rare seizure disorder characterized by both myoclonic and tonic-clonic (grand mal) seizures.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Myoclonic Epilepsy?
Treatment for myoclonic epilepsy depends on the type, frequency, and severity of the seizures and may include anti-seizure (anti-epileptic) medications, ketogenic diet, vagus nerve stimulator (VNS) implantation, and surgery.
Who are the top Myoclonic Epilepsy Local Doctors?
Elite in Myoclonic Epilepsy
Elite in Myoclonic Epilepsy
Referral may be required

Werner K Doyle M.D. PC

223 E 34th St, 
New York, NY 
212-263-8870
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Orrin Devinsky is a Neurologist practicing medicine in New York, New York. Dr. Devinsky is rated as an Elite provider by MediFind in the treatment of Myoclonic Epilepsy. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.

Elite in Myoclonic Epilepsy
Elite in Myoclonic Epilepsy
Referral may be required

U Of M Neurology Clinic

1500 E Medical Center Dr, 
Ann Arbor, MI 
734-936-9020
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jack Parent is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Parent is rated as an Elite provider by MediFind in the treatment of Myoclonic Epilepsy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Myoclonic Epilepsy, Epilepsy, Epilepsy with Myoclonic-Atonic Seizures, and Dravet Syndrome. Dr. Parent is board certified in Neurology and Clinical Neurophysiology. Dr. Parent is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Myoclonic Epilepsy
Distinguished in Myoclonic Epilepsy
Referral required

St. Vincent Neurosurgery

1041 North 29th Street, 
Billings, MT 
406-237-5577
Languages Spoken:
English, Spanish
See accepted insurances

Javier Echeverri is a Neurologist practicing medicine in Billings, Montana. Dr. Echeverri is rated as a Distinguished provider by MediFind in the treatment of Myoclonic Epilepsy. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Essential Tremor, Parkinson's Disease, Movement Disorders, Epilepsy with Myoclonic-Atonic Seizures, and Deep Brain Stimulation.

View All Doctors
What are the latest Myoclonic Epilepsy Clinical Trials?
Phase 1-2, Open-Label, Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION337 in Patients With Dravet Syndrome
Phase 1-2, Open-Label, Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION337 in Patients With Dravet Syndrome
Enrollment Status: Recruiting
Publish Date: September 03, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

Summary: The primary purpose of this study is to evaluate the safety and tolerability of ION337 in participants with Dravet syndrome (DS).

Match to trials
Find the right clinical trials for you in under a minute
Get started
EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome
EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug, Other
Study Phase: Phase 3

Summary: The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.

View All Clinical Trials